Johnson & Johnson Hit With $8 Billion Jury Verdict in Risperdal Suit
By BY MIHIR ZAVERI AND KATIE THOMAS from NYT Health A Philadelphia jury found that a subsidiary downplayed the risks that the anti-psychotic drug could lead to breast growth in boys. https://ift.tt/31YDhZP
Hiç yorum yok:
Yorum Gönder